The Focal Therapy Clinic

25/05/2026

chatbots support patients in ways that many doctors find difficult - acting less diagnostician, more health coach

Even doctors can learn something from A.I.

22/05/2026

updated guidance on PSA testing from Cochrane

An updated Cochrane review has concluded there is evidence that PSA screening reduces prostate cancer deaths.

21/05/2026

thanks to Alex for sharing his very informative story

Prostate Cancer – A case study Disclaimer: Prostate for Dummies is not a medical website. Prostate Cancer – A case study applies to one individual and only relates what he found and what worked for…

20/05/2026

Study shows that LLM agents can improve patient engagement and health education

Cancer patients often lack timely education and personalized support due to clinician workload. This quality improvement study develops and evaluates a Large Language Model (LLM) agent, MedEduChat, which is integrated with the clinic’s electronic health records (EHR) and designed to enhance prosta...

19/05/2026

47% of UK men do not feel fully informed about treatment options for prostate cancer at diagnosis

18/05/2026

24-month data is released from PRESERVE trial on use of Nanoknife/IRE in treating prostate cancer

LATHAM, N.Y., May 13, 2026--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced two-year results from the PRESERVE pivotal tri...

16/05/2026

here in Washington, DC to share practice and explore advances in focal therapy

15/05/2026

the success of cryoablation as a treatment modality depends on the tumour position & the clinical setting. The important point is that treatment should be matched to the cancer, not chosen because one technology sounds newer or more advanced

Learn what focal cryoablation is, how it treats prostate cancer, and how it compares with HIFU and NanoKnife focal therapy options for localised disease.

14/05/2026

analysis from the Telegraph analysis shows just 28% of men received answers within target timeframe of 28 days, versus 67% for breast cancer

Telegraph analysis shows just 28 per cent of men received answers within target timeframe of 28 days, versus 67 per cent for breast cancer

13/05/2026

Overall, patients appear to prioritize avoiding bowel and sexual side effects after prostate cancer treatment. However, a subset of older patients may have strong preferences against surgery or the prolonged use of a catheter

To evaluate patient preferences for intermediate-risk prostate cancer treatment and determine how these preferences vary across demographic groups using a discrete choice experiment.We recruited patients with intermediate-risk prostate cancer from a single-center urology clinic.

12/05/2026

"Men know more about buying cars than anything about prostates. And that’s the problem. There’s so much information that comes down the line at you very quickly, it’s completely overwhelming"

After having a prostatectomy and making a podcast about the disease, the broadcaster Jon Holmes thought he knew everything about the subject. But he was wrong